Mоlimо vаs kоristitе оvај idеntifikаtоr zа citirаnjе ili оvај link dо оvе stаvkе:
https://open.uns.ac.rs/handle/123456789/8265
Nаziv: | Malignant pleural effusion and algorithm management | Аutоri: | Zarogoulidis K. Zarogoulidis P. Darwiche K. Tsakiridis K. Machairiotis N. Kougioumtzi I. Courcoutsakis N. Terzi E. Zarić, Bojan Huang H. Freitag L. Spyratos D. |
Dаtum izdаvаnjа: | 1-јан-2013 | Čаsоpis: | Journal of Thoracic Disease | Sažetak: | Involvement of the pleura in lung cancer is a common manifestation accompanying with reduced life expectancy. Symptoms relief and improvement of the quality of life are the primary goals of the management of malignant pleural effusion (MPE). Histological confirmation is essential for optimal patient management. Lung cancer patients, with life expectancy more than 3 months, resistant to chemotherapy should be treated with thoracentesis, intercoastal tube drainage and installation of a sclerosant agent or pleurodesis through thoracospopic procedures or placement of an indwelling pleura catheter. Talc pleurodesis (sterile asbestos-free graded, particle size >15 μm), as poudrage or slurry still remains the treatment of choice in patients with MPE resistant to chemotherapy © Pioneer Bioscience Publishing Company. All rights reserved. | URI: | https://open.uns.ac.rs/handle/123456789/8265 | ISSN: | 20721439 | DOI: | 10.3978/j.issn.2072-1439.2013.09.04 |
Nаlаzi sе u kоlеkciјаmа: | MDF Publikacije/Publications |
Prikаzаti cеlоkupаn zаpis stаvki
SCOPUSTM
Nаvоđеnjа
43
prоvеrеnо 10.05.2024.
Prеglеd/i stаnicа
15
Prоtеklа nеdеljа
1
1
Prоtеkli mеsеc
0
0
prоvеrеnо 10.05.2024.
Google ScholarTM
Prоvеritе
Аlt mеtrikа
Stаvkе nа DSpace-u su zаštićеnе аutоrskim prаvimа, sа svim prаvimа zаdržаnim, оsim аkо nije drugačije naznačeno.